Synergy Financial Corp Apr 2002 - Jun 2008
Loan Officer
Hkh & Associates Apr 2002 - Jun 2008
President and Chief Executive Officer
Skills:
Real Estate Commercial Real Estate Loans Investment Properties Residential Homes Foreclosures Property Management Short Sales Investors Condos Reo Single Family Homes Real Estate Economics Real Estate Development First Time Home Buyers Finance Fha
The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.
Modulators Of Pharmacokinetic Properties Of Therapeutics
Manoj C. Desai - Pleasant Hill CA, US Hon C. Hui - San Mateo CA, US Hongtao Liu - Cupertino CA, US Jianyu Sun - San Mateo CA, US Lianhong Xu - Palo Alto CA, US
Manoj C. Desai - Pleasant Hill CA, US Randall L. Halcomb - Foster City CA, US Paul Hrvatin - South San Francisco CA, US Hon Chung Hui - San Mateo CA, US Ryan McFadden - Foster City CA, US Paul A. Roethle - San Francisco CA, US Hong Yang - Fremont CA, US
Kerim Babaoglu - Pacifica CA, US Constantine G. Boojamra - San Francisco CA, US Eugene J. Eisenberg - San Carlos CA, US Hon Chung Hui - San Mateo CA, US Richard L. Mackman - Milbrae CA, US Jay P. Parrish - Redwood City CA, US Michael Sangi - Oakland CA, US Oliver L. Saunders - San Mateo CA, US Dustin Siegel - Foster City CA, US David Sperandio - Palo Alto CA, US Hai Yang - San Mateo CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07D 487/04 A61K 31/519
US Classification:
5142332, 51425931, 544117, 544281
Abstract:
The invention provides compounds of Formula I or Formula II:.
Modulators Of Pharmacokinetic Properties Of Therapeutics
Manoj C. Desai - Pleasant Hill CA, US Allen Y. Hong - Pasadena CA, US Hon C. Hui - San Mateo CA, US Hongtao Liu - Cupertino CA, US Randall W. Vivian - San Mateo CA, US Lianhong Xu - Palo Alto CA, US
Assignee:
Gilead Sciencs, Inc. - Foster City CA
International Classification:
A61K 31/5355
US Classification:
5142368
Abstract:
The present application provides for a compound of Formula IV,.
Randall L. Halcomb - Foster City CA, US Paul Hrvatin - South San Francisco CA, US Hon Chung Hui - San Mateo CA, US Ryan McFadden - Foster City CA, US Paul A. Roethle - San Francisco CA, US Hong Yang - Fremont CA, US
Manoj C. Desai - Pleasant Hill CA, US Allen Y. Hong - Pasadena CA, US Hon C. Hui - San Mateo CA, US Hongtao Liu - Cupertino CA, US Randall W. Vivian - San Mateo CA, US Lianhong Xu - Palo Alto CA, US
The present application provides for a compound of Formula IV,or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.
The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.